Author:
Gore Sara,Forrest Graeme N.
Publisher
Springer Science and Business Media LLC
Reference95 articles.
1. Perfect JR, Bicanic T. Cryptococcosis diagnosis and treatment: what do we know now. Fungal Genet Biol. 2015;78:49–54. https://doi.org/10.1016/j.fgb.2014.10.003.
2. • Kwon-Chung KJ, Bennett JE, Wickes BL, Meyer W, Cuomo CA, Wollenburg KR, et al. The case for adopting the “species complex” nomenclature for the etiologic agents of Cryptococcosis. mSphere. 2017;2(1):e00357. https://doi.org/10.1128/mSphere.00357-16Explains the proposed cryptococcal species nomenclature changes.
3. Jin L, Cao JR, Xue XY, Wu H, Wang LF, Guo L, et al. Clinical and microbiological characteristics of Cryptococcus gattii isolated from 7 hospitals in China. BMC Microbiol. 2020;20(1):73. https://doi.org/10.1186/s12866-020-01752-4.
4. Steenbergen JN, Casadevall A. Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City. J Clin Microbiol. 2000;38(5):1974–6.
5. Harris JR, Lockhart SR, DeBess E, Marsden-Haug N, Goldoft M, Wohrle R, et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. ClinInfectDis. 2011;53(12):1188–95.